Top-News
Sonstige Kanada

Theratechnologies News

Aktie
WKN:  A3ERKM ISIN:  CA88338H7040 US-Symbol:  THTX
1,17 €
+0,00 €
0,00%
10.05.24 21:44:01
Handeln Depot/Watchlist
Aktienanzahl *
23,46 Mio.
Marktkapitalisierung *
26,35 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 31.07.2023

Theratechnologies News

07.02.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX PR Newswire
30.01.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX PR Newswire
21.12.23 - PR Newswire
Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement
Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement PR Newswire
26.12.22 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theratechnologies Inc. - THTX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theratechnologies Inc. - THTX PR Newswire
27.04.22 - PR Newswire
THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORY
THERATECHNOLOGIES TO FOCUS ITS COMMERCIALIZATION ACTIVITIES ON THE NORTH AMERICAN TERRITORY PR Newswire
23.11.21 - PR Newswire
Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended
Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-​The-Market Facility to be Extended PR Newswire
26.10.21 - GlobeNewswire
Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1
MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the ...
30.09.20 - GlobeNewswire
Theratechnologies to Present at the H.C. Wainwright 4th Annual NASH Investor Conference on October 5
MONTREAL, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the ...
10.09.20 - PR Newswire
Theratechnologies Announces Launch of Trogarzo® in Germany
Theratechnologies Announces Launch of Trogarzo® in Germany PR Newswire
10.09.20 - GlobeNewswire
Theratechnologies Announces Launch of Trogarzo® in Germany
First commercial launch in Europe
02.03.20 - PR Newswire
Change to Theratechnologies Management
Change to Theratechnologies Management PR Newswire
07.11.19 - GlobeNewswire
Trogarzo® Remains Effective Close to a Decade After Treatment Initiation
MONTREAL, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-​stage biopharmaceutical company, is ...
27.09.19 - GlobeNewswire
Europäische Kommission erteilt Zulassung für Trogarzo®
MONTREAL, Kanada, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) freut sich bekannt zu geben, dass Trogarzo ® (Ibalizumab) ...
26.09.19 - GlobeNewswire
European Commission Approves Trogarzo®
MONTREAL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Trogarzo ® (ibalizumab) was approved today ...
26.09.19 - PR Newswire
Toronto Stock Exchange Introduces the TSX30
Toronto Stock Exchange Introduces the TSX30 Canada NewsWire
06.03.18 - PR Newswire
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-​uiyk) Injection, the First HIV-1 Inhibitor and Long-​Acting Monoclonal Antibody for ...
06.03.18 - PR Newswire
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-​uiyk) Injection, the First HIV-1 Inhibitor and Long-​Acting Monoclonal Antibody for ...
06.03.18 - PR Newswire
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-​uiyk) Injection, the First HIV-1 Inhibitor and Long-​Acting Monoclonal Antibody for ...
06.03.18 - PR Newswire
IIROC Trade Resumption - TH
IIROC Trade Resumption - TH Canada NewsWire
06.03.18 - PR Newswire
IIROC Trading Halt - TH
IIROC Trading Halt - TH Canada NewsWire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »